scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Venus Remedies Ltd

Feedback
Venus Remedies Ltd

Venus Remedies Ltd (VENUSREM) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 24,866
Mar 10, 2025 15:54 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹298.25
₹-7.25 (-2.37%)
₹295 Low
Today’s Performance
₹310.1 High
₹270.25 Low
52 Week’s Performance
₹427.9 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -2.37%
  • 1 Week 3.09%
  • 1 Month -15.27%
  • 3 Months -10.09%
  • 6 Months -14.41%
  • 1 Year -8.59%
  • 3 Years 3.84%
  • 5 Years 58.54%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 10.00
  • Beta 0.91
  • 52-Week Low (₹) 270.25
  • 52-Week High (₹) 427.90
  • Price-to-Book (X)* 0.83
  • Dividend Yield (%) 0.00
  • Price-to-Earnings (P/E) (X)* 11.78
  • Earnings Per Share (₹) 26.06
  • Sector Price Earning (X)* 32.69
  • Market Cap (₹ Cr.)* 408.36
  • * Vaues as of last close price

COMPETITORS

BT TV

Yogi Adityanath Slams Aurangzeb Admirers, Talks ‘Virasat & Vikas’ At India Today Conclave 2025 3:43 Yogi Adityanath Slams Aurangzeb Admirers, Talks ‘Virasat & Vikas’ At India Today Conclave 2025
#IndiaTodayConclave2025 | Yogi Adityanath Exclusive On Mahakumbh, Development, Holi & More 78:48 #IndiaTodayConclave2025 | Yogi Adityanath Exclusive On Mahakumbh, Development, Holi & More
Finance Minister Nirmala Sitharaman On SBI Revolutionising Banking For The Future 1:15 Finance Minister Nirmala Sitharaman On SBI Revolutionising Banking For The Future
U.P CM Yogi Adityanath On Breaking Myths, Attracting Investors & UP’s Role In Viksit Bharat 4:17 U.P CM Yogi Adityanath On Breaking Myths, Attracting Investors & UP’s Role In Viksit Bharat
Is the IT Boom Over? Expert Warns of 'Clouded' Future Amidst Multiple Headwinds 2:46 Is The IT Boom Over? Expert Warns Of 'Clouded' Future Amidst Multiple Headwinds
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE

No Data For Block Deal.

*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Jan 24, 2024 Sell
BNP PARIBAS ARBITRAGE
  • Qty 66948
  • Average Price ₹380.24
Jan 24, 2024 PURCHASE
SOCIETE GENERALE
  • Qty 66838
  • Average Price ₹380.25
Nov 10, 2023 PURCHASE
GRAVITON RESEARCH CAPITAL LLP
  • Qty 168234
  • Average Price ₹322.38
Nov 10, 2023 Sell
GRAVITON RESEARCH CAPITAL LLP
  • Qty 168234
  • Average Price ₹322.43
May 31, 2022 PURCHASE
PAWAN CHAUDHARY
  • Qty 84246
  • Average Price ₹221.95
May 12, 2022 Sell
GUTTIKONDA RAJASEKHAR
  • Qty 69399
  • Average Price ₹211.46
Oct 27, 2021 PURCHASE
XTX MARKETS LLP
  • Qty 67949
  • Average Price ₹558.99
Oct 27, 2021 Sell
XTX MARKETS LLP
  • Qty 69468
  • Average Price ₹561.89
Aug 09, 2021 PURCHASE
GRAVITON RESEARCH CAPITAL LLP
  • Qty 97760
  • Average Price ₹616.58
Aug 09, 2021 Sell
GRAVITON RESEARCH CAPITAL LLP
  • Qty 97760
  • Average Price ₹616.96
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Venus Remedies Ltd share price previously?
Venus Remedies Ltd share price was down by -2.37% from the previous closing price of ₹305.50.
Who are peers of Venus Remedies Ltd?
The peers of Venus Remedies Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd,
Who is/are the promoter/promoters of Venus Remedies Ltd?
The promotor/promotors of Venus Remedies Ltd are Pawan Chaudhary, Manu Chaudhary, Peeyush Jain, Ashutosh Jain, Neha Kodan, Navdeep Sud, Savita Gupta, Akshansh Chaudhary, Nps Monga, Jagdish Chander Sharma, Anil Kumar.
What has been 52-week high of Venus Remedies Ltd stocks?
The highest price of Venus Remedies Ltd stock is ₹427.90 in the last 52-week.
What is the share price of Venus Remedies Ltd (VENUSREM) today on NSE?
As on Mar 10, 2025, Venus Remedies Ltd (VENUSREM)’s share price on NSE is Rs 298.25
What is the market cap of Venus Remedies Ltd (VENUSREM?)
The current market capitalisation of Venus Remedies Ltd (VENUSREM) is 408.36 crores
What is Venus Remedies Ltd Share symbol?
The symbol of Venus Remedies Ltd is VENUSREM.
What is the PE ratio of Venus Remedies Ltd (VENUSREM)?
The current PE ratio of Venus Remedies Ltd (VENUSREM) is 11.78.
What is the PB ratio of Venus Remedies Ltd (VENUSREM)?
The current PB ratio of Venus Remedies Ltd (VENUSREM) is 0.83.
Today’s High & Low share prices of Venus Remedies Ltd (VENUSREM) on NSE?
Today, the share price of Venus Remedies Ltd (VENUSREM) on NSE touched a high of Rs 310.1 and a low of Rs 295
What price did Venus Remedies Ltd (VENUSREM) shares open on the NSE today?
On NSE, the share price of Venus Remedies Ltd (VENUSREM) opened at Rs 310.1
What is the 52-week high of Venus Remedies Ltd (VENUSREM)?
The 52-week high price of Venus Remedies Ltd (VENUSREM) is Rs 427.9
What is the 52-week low of Venus Remedies Ltd (VENUSREM) ?
The 52-week low price of Venus Remedies Ltd (VENUSREM) is Rs 270.25

ABOUT VENUS REMEDIES

Venus Remedies Ltd, incorporated in the year 1989, has its registered office in S C No 857 Cabin No 10 2nd Flr, N A C Manimajra, Chandigarh, Chandigarh, 160101. The main industry in which Venus Remedies Ltd operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for Venus Remedies Ltd is/are J K Jain & Associates. In the main management, Pawan Chaudhary is chairman and Neha Kodan is the company secretary for Venus Remedies Ltd.

  • PC Pawan Chaudhary Chairman & Managing Director
  • MC Manu Chaudhary Joint Managing Director
  • PJ Peeyush Jain Deputy Managing Director
  • AJ Ashutosh Jain Executive Director
  • NK Neha Kodan Company Sec. & Compli. Officer
  • NS Navdeep Sud Independent Director
  • SG Savita Gupta Independent Director
  • AC Akshansh Chaudhary Whole-time Director
  • NM Nps Monga Independent Director
  • JCS Jagdish Chander Sharma Independent Director
  • AK Anil Kumar Independent Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement